HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
RDGT
Ridgetech Inc.
There isn't enough reported data to score RDGT yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
RDGT Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
RDGT's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
RDGT PE Valuation
RDGT has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
RDGT Forward outlook
There aren't enough analyst estimates for RDGT to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
RDGT has the stronger earnings trend. Trailing diluted EPS is down 257% for HIMS versus RDGT down 100%.
RDGT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2021 | -$1,098,000.00 | -$132,750.00 |
| Q4 2020 | -$1,559,250.00 | -1185% |
| Q3 2020 | -$641,250.00 | -$353,025.00 |
| Q2 2020 | -$641,250.00 | -$245,025.00 |
| Q1 2020 | -$965,250.00 | -$839,025.00 |
| Q4 2019 | $143,775.00 | +$3,460,500.00 |
| Q3 2019 | -$288,225.00 | +$3,136,500.00 |
| Q2 2019 | -$396,225.00 | +$2,974,500.00 |
RDGT has returned to profit: it earned $276.00 per share over the past year, after losing money the year before.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the stronger quarterly revenue trend. Revenue is up 49% for HIMS versus down 8.7% for RDGT.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
RDGT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $69.4M | -42% |
| Q3 2025 | $62.8M | -12% |
| Q1 2025 | $120M | +58% |
| Q3 2024 | $71.2M | -9.4% |
| Q1 2024 | $76M | -49% |
| Q1 2023 | $148.8M | -9.5% |
| Q1 2022 | $164.4M | +360% |
| Q1 2021 | $35.7M | +18% |
RDGT's revenue has slid since its 2022 peak: $69M last quarter, down 8.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q1 2026 | -2.6% | +2.4 points |
| Q3 2025 | -0.1% | -0.5 points |
| Q1 2025 | -0.9% | +13 points |
| Q3 2024 | -3.1% | -1.5 points |
| Q1 2024 | -5% | -3.5 points |
| Q3 2023 | 0.3% | +18 points |
| Q1 2023 | -14% | -9.1 points |
| Q1 2022 | -1.6% | -0.3 points |
RDGT's operating margin was −2.6% last quarter, up 2.4 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
RDGT has the stronger cash trend. Its trailing FCF is down 77% versus its history, compared with HIMS at down 84%.
RDGT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2025 | $1.1M | +$5.3M |
| Q3 2024 | -$10.1M | -1517% |
| Q1 2024 | -$4.2M | -$797.7K |
| Q1 2023 | -$3.4M | +$2.1M |
| Q1 2022 | -$5.5M | -145% |
| Q1 2021 | $12.1M | +219% |
| Q4 2020 | -$12.1M | +$387.3K |
| Q3 2020 | $5M | -44% |
RDGT's free cash flow was −$13M over the past year, against −$9M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over RDGT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
RDGT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.6% | +2.1K shares |
| 1 year | +1048% | +35.6K shares |
| 3 years | +650450% | +39K shares |
| 5 years | +780560% | +39K shares |
| Available history | +1301000% | +39K shares |
RDGT has 39,033 diluted shares, up 1048% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
| Q4 2019 | — |
| Q3 2019 | — |
| Q2 2019 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
RDGT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | -23.5x | Net Cash |
| Q1 2019 | 20.8x | High |
| Q3 2016 | 3.2x | Elevated |
RDGT has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
RDGT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.8 | Neutral |
| Stochastic | 28.7 | Neutral |
RDGT's weekly RSI is 35 (neutral) and its Stochastic is 29 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
RDGT PE vs Healthcare Sector
| Metric | RDGT | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
RDGT has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
RDGT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.91 | 22% above |
| 20 week MA | $0.99 | 12% above |
| 50 week MA | $122.2 | 99% below |
| 100 week MA | $171.8 | 99% below |
| 200 week MA | $1,289.0 | 100% below |
RDGT has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over RDGT on returns for 2026, with the stronger performance.
RDGT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $66,240.0 | $37,080.0 | -44% |
| 2021 | $37,080.0 | $14,047.6 | -62% |
| 2022 | $14,047.6 | $11,850.0 | -16% |
| 2023 | $11,850.0 | $666.0 | -94% |
| 2024 | $666.0 | $271.5 | -59% |
| 2025 | $271.5 | $483.0 | +78% |
| 2026 YTD | $483.0 | $1.11 | -100% |
RDGT has finished lower in five of the last six years. It's down 100% so far in 2026.